SCOPE Analytic Treatment Interruption Protocol

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT04359186
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Treatment Interruption Arm — OTHER
    Individuals with HIV on suppressive ART will interrupt their ART.

Study Details

The goal of this study is to understand the interaction between HIV and the host at the earliest stages when HIV medications are paused. Volunteers with HIV will interrupt antiretroviral therapy (ART) and then have intensive studies preformed two to three times per week. Most will resume therapy within three weeks, even if the virus does not rebound during this time.

Key Dates

Start date
Oct 15, 2020
Status verified
Jan 2026
Primary completion
Dec 31, 2027
Completion
Jun 30, 2028

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Treatment Interruption Arm

Primary Outcome Measure

Acute retroviral syndrome [ Time Frame: Week 0 through Month 6 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California San FranciscoSan FranciscoCalifornia94110

Find similar trials in San Francisco, CA

By condition
HIV
By specialty
Infectious disease
By research site
University of California San Francisco· San Francisco, CA

Related Studies